Biomarker profiles of acute heart failure patients with a mid-range ejection fraction [PDF]
, 2017 OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a ...
Bloomfield, Daniel M +16 more
core +15 more sources
Microvascular Disease with Heart Failure with Reduced and Preserved Ejection Fraction in Patients with Type 2 Diabetes [PDF]
, 2020 Aims: Identification of patients with type 2 diabetes (T2D) at increased risk of incident heart failure (HF) beyond traditional risk factors such as prior myocardial infarction (MI) might allow selection of patients who would benefit from preventative ...
Doney, Alexander +5 more
core +2 more sources
Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction [PDF]
, 2019 Pulmonary hypertension in the setting of heart failure with preserved ejection fraction (PH-HFpEF) is a growing public health problem that is increasing in prevalence.
Gladwin, Mark T. +2 more
core +1 more source
Impact of diabetes mellitus on ventricular structure, arterial stiffness, and pulsatile hemodynamics in heart failure with preserved ejection fraction [PDF]
, 2019 Background-Heterogeneity in the underlying processes that contribute to heart failure with preserved ejection fraction (HFpEF) is increasingly recognized.
Akers, Scott R. +8 more
core +2 more sources
Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
Рациональная фармакотерапия в кардиологии, 2021 Heart failure with preserved ejection fraction (HFpEF) is a syndrome associated with high morbidity and mortality rates. Little progress has been in the treatment of this condition since its introduction some 30 years ago.
A. A. Shchendrygina +9 more
doaj +1 more source
Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme [PDF]
, 2016 Aims We investigated the association between worsening renal function (WRF) that occurs during renin–angiotensin–aldosterone system inhibition initation and outcome in heart failure (HF) patients with preserved ejection fraction (HFPEF) and compared ...
Brenner +21 more
core +1 more source
STEP-HFpEF: A Large Step for HFpEF. [PDF]
Journal of the American College of CardiologyContains fulltext : 307714.pdf (Publisher’s version ) (Open Access)
Kimmenade, R.R.J. van, Hassing, C.
openaire +3 more sources
Медицинский вестник Юга России, 2021 Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with heart ...
A. A. Borisov +2 more
doaj +1 more source
Effect of selective heart rate slowing in heart failure with preserved ejection fraction [PDF]
, 2015 Background Heart failure with preserved ejection fraction (HFpEF) is associated with significant morbidity and mortality but is currently refractory to therapy.
Ashrafian, Houman +12 more
core +2 more sources
The Concept of "Heart Failure with Preserved Ejection Fraction": Time for a Critical Reappraisal
Reviews in Cardiovascular Medicine, 2023 Heart failure with preserved ejection fraction (HFpEF) is frequently observed in elderly physically deconditioned subjects, mainly women with hypertension, obesity, glucose intolerance/diabetes, atrial fibrillation, anaemia, coronary artery disease ...
Gabriele Fragasso
doaj +1 more source